Sphingotec GmbH
Records under this name other than the patents Sphingotec GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,637,256 | Immunoassay for determining the release of neurotensin into the circulation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,520,512 | Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,340,240 | Method for predicting the risk of obesity in a subject Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,900,978 | Method for predicting the risk of obesity in a subject Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,838,245 | Use of precursors of tachykinins and/or their fragments in medical diagnostic Term ended Term ended Jul 2, 2025 · From the USPTO record | Term ended | Term ended Jul 2, 2025 | From the USPTO record |
| US 9,188,591 | Use of precursors of tachykinins and/or their fragments in medical diagnostic Lapsed on the fee record Ended Nov 17, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 17, 2023 | From the USPTO record |
| US 8,916,388 | In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative disorders Lapsed on the fee record Ended Dec 23, 2018 · From the USPTO record | Lapsed on the fee record | Ended Dec 23, 2018 | From the USPTO record |
| US 7,132,246 | Use of soluble cytokeratin-1-fragments in diagnostics and therapy Lapsed on the fee record Ended Nov 7, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 7, 2018 | From the USPTO record |
| US 7,659,075 | Method for the diagnosis of sepsis with determination of soluble cytokeratin fragments Lapsed on the fee record Ended Feb 9, 2018 · From the USPTO record | Lapsed on the fee record | Ended Feb 9, 2018 | From the USPTO record |
| US 7,622,262 | Method for diagnosing neoplasms Lapsed on the fee record Ended Nov 24, 2017 · From the USPTO record | Lapsed on the fee record | Ended Nov 24, 2017 | From the USPTO record |